ScripNovartis AG outlined the details of its spin-off plans for its generics and biosimilars business Sandoz on 18 August, revealing the financial terms for the big pharma’s shareholders and the date of t
ScripEager to get ahead, gene therapy and gene-editing companies in China are now racing to secure funding and get their treatments in front of patients. Given the promise these modalities potentially offe
In VivoFounded in 2017, Belief Biomed Inc. has fast grown to become one of the front-runners in gene therapy development in China. The Shanghai-based company, backed by Qiming Venture Partners, has already
ScripFounded in 2017, Belief Biomed Inc. has fast grown to become one of the front-runners in gene therapy development in China. The Shanghai-based company, backed by Qiming Venture Partners, has already